AD-related markers, such as amyloid beta deposits, hyperphosphorylated tau aggregates, and inflammation, can also appear in the retinas of patients, posing the question of whether the retina can be used as a potential, easily accessible window for diagnostics.8 This evidence concerns the gene MAPT and Alzheimer disease.